Regulatory actions for July 31, 2026Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 3D Systems, Aspen, Capricor, Caristo, Cytokinetics, Immunitybio, J&J, Nipro, Pfizer, Kelun, Smith+Nephew, Stevanato, Teleflex, VB Spine.